For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...

When I was diagnosed with colon cancer, I had a hard time deciding what my legacy should be, but once I realized what it was, ...

Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.

Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...